A before-and-after image documents two appearances under conditions that may be incompletely described. It does not establish why a change occurred, how typical it is or when another person should expect the same outcome. Those limitations become more important when images are used to promote investigational products.

A timeline needs a defined outcome

Body weight, wound healing, skin appearance and physical performance change on different timescales. The starting condition, measurement method and follow-up period affect what can be concluded. Combining them into a universal peptide results schedule hides rather than resolves those differences.

FTC guidance explains that testimonials cannot support claims a seller could not substantiate directly. An unusual result can also imply that typical users should expect the same result unless the presentation is appropriately supported and qualified. A small disclaimer does not automatically correct an otherwise misleading message. FTC Health Products Compliance Guidance

Clinical trials track more than visible change

A meaningful trial predefines its outcomes, uses a comparison group and reports how many participants completed follow-up. It should distinguish an average effect from the range of individual responses. It should also report adverse effects and discontinuation, because a treatment that changes an outcome may still be unsuitable for some participants.

Published obesity trials illustrate how results are tied to a particular population and follow-up interval rather than a generic promise. The REDEFINE 1 study, for example, evaluated a specific investigational combination within a defined trial. Its design cannot validate photographs attributed to unrelated retail products. REDEFINE 1 randomized trial

For educational content, AXON can replace a results calendar with a set of evidence questions: What changed? How was it measured? Compared with what? How many people were studied? What happened to those who stopped? These questions produce a more honest account than predicting visible results by week. No personal outcome or safe waiting period can be inferred from the examples discussed here.